Targeting RNA-binding Motif Protein 39 for Arginine Reduction: Unveiling Metabolic Vulnerability in Arginine-Dependent Liver Cancer

Aoxue Li,Hongjuan Cui,Erhu Zhao

DOI: https://doi.org/10.1002/mco2.581

2024-01-01

MedComm

Abstract:Cancer is increasingly acknowledged as a metabolic disease, characterized by metabolic reprogramming as its hallmark. However, the precise mechanisms behind this phenomenon and the factors contributing to tumorigenicity are still poorly understood. In a recent publication in Cell, Mossmann and colleague reported a study unveiling arginine as a molecule with second messenger-like properties that reshapes metabolism to facilitate the tumor development in hepatocellular carcinoma (HCC). Their research revealed that the RNA-binding motif protein 39 (RBM39)-mediated increase in asparagine synthesis results in increased arginine uptake. This establishes a positive feedback loop that sustains elevated levels of arginine and facilitates oncogenic metabolic reprogramming. Additionally, Mossmann et al. demonstrated that depleting RBM39 with indisulam effectively disrupts the proto-oncogenic metabolic reprogramming in HCC. This discovery presents a novel treatment strategy for arginine-dependent liver cancers. In a recent publication in Cell, Mossmann and colleagues presented a study uncovering arginine's role as a molecule with characteristics akin to second messengers, reshaping metabolism to promote tumor growth in hepatocellular carcinoma (HCC). Their investigation demonstrated that the RNA-binding motif protein 39 (RBM39) drives heightened asparagine synthesis, leading to elevated arginine absorption. This sets up a reinforcing cycle that supports sustained arginine levels and promotes oncogenic metabolic alterations. This finding introduces a fresh therapeutic approach for arginine-dependent liver malignancies. image